Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome - ScienceDirect
atypical hemolytic uremic syndrome - List of Frontiers' open access articles
PDF) First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome
Frontiers Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS
PDF) Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
